The researchers will study the application of a commercial pulsed magnetic stimulating
device to the feet of patients with moderate-severe foot pain secondary to diabetic
peripheral neuropathy (DPN).
- DPN stage 2 and 3; symptomatic > 6 months
- Pacemaker in patient or mate